vs
American Resources Corp(AREC)与科迪华(CTVA)财务数据对比。点击上方公司名可切换其他公司
科迪华的季度营收约是American Resources Corp的23696969.7倍($3.9B vs $165)。科迪华净利率更高(-14.1% vs -4667098.8%,领先4667084.7%)。科迪华同比增速更快(-1.7% vs -99.9%)。过去两年科迪华的营收复合增速更高(-6.7% vs -99.5%)
REX美国资源公司成立于1980年,总部位于俄亥俄州代顿市,是美国本土的乙醇、酒糟及天然气生产商与销售商,同时也开展能源领域企业投资控股业务。该公司全资控股三家关联企业,截至2012年,旗下拥有22家全国性门店,同时参股五家乙醇生产项目。
科迪华是一家美国农业科技企业,主营种子与作物保护产品,涵盖除草剂、杀虫剂、杀菌剂及生物制剂,业务覆盖全球110个国家,总部位于印第安纳州印第安纳波利斯,旗下大部分种子产品以先锋良种国际品牌销售。
AREC vs CTVA — 直观对比
营收规模更大
CTVA
是对方的23696969.7倍
$165
营收增速更快
CTVA
高出98.2%
-99.9%
净利率更高
CTVA
高出4667084.7%
-4667098.8%
两年增速更快
CTVA
近两年复合增速
-99.5%
损益表 — Q3 2025 vs Q4 2025
| 指标 | ||
|---|---|---|
| 营收 | $165 | $3.9B |
| 净利润 | $-7.7M | $-552.0M |
| 毛利率 | -41374.5% | 42.4% |
| 营业利润率 | -2656743.0% | -13.6% |
| 净利率 | -4667098.8% | -14.1% |
| 营收同比 | -99.9% | -1.7% |
| 净利润同比 | 27.5% | -1246.3% |
| 每股收益(稀释后) | $-0.05 | $-0.80 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
AREC
CTVA
| Q4 25 | — | $3.9B | ||
| Q3 25 | $165 | $2.6B | ||
| Q2 25 | — | $6.5B | ||
| Q1 25 | $31.9K | $4.4B | ||
| Q4 24 | $49.7K | $4.0B | ||
| Q3 24 | $235.4K | $2.3B | ||
| Q2 24 | $4.1K | $6.1B | ||
| Q1 24 | $94.0K | $4.5B |
净利润
AREC
CTVA
| Q4 25 | — | $-552.0M | ||
| Q3 25 | $-7.7M | $-320.0M | ||
| Q2 25 | — | $1.3B | ||
| Q1 25 | $-6.7M | $652.0M | ||
| Q4 24 | $-14.6M | $-41.0M | ||
| Q3 24 | $-10.6M | $-524.0M | ||
| Q2 24 | $-7.0M | $1.1B | ||
| Q1 24 | $-7.0M | $419.0M |
毛利率
AREC
CTVA
| Q4 25 | — | 42.4% | ||
| Q3 25 | -41374.5% | 37.2% | ||
| Q2 25 | — | 54.6% | ||
| Q1 25 | -470.0% | 47.0% | ||
| Q4 24 | — | 37.3% | ||
| Q3 24 | -85.8% | 32.7% | ||
| Q2 24 | — | 52.3% | ||
| Q1 24 | -938.6% | 43.2% |
营业利润率
AREC
CTVA
| Q4 25 | — | -13.6% | ||
| Q3 25 | -2656743.0% | -14.1% | ||
| Q2 25 | — | 27.9% | ||
| Q1 25 | -15608.8% | 17.7% | ||
| Q4 24 | -21019.9% | 2.2% | ||
| Q3 24 | -3750.1% | -27.2% | ||
| Q2 24 | -152122.5% | 21.9% | ||
| Q1 24 | -7158.3% | 10.7% |
净利率
AREC
CTVA
| Q4 25 | — | -14.1% | ||
| Q3 25 | -4667098.8% | -12.2% | ||
| Q2 25 | — | 20.4% | ||
| Q1 25 | -20847.7% | 14.8% | ||
| Q4 24 | -29402.3% | -1.0% | ||
| Q3 24 | -4513.4% | -22.5% | ||
| Q2 24 | -170873.1% | 17.2% | ||
| Q1 24 | -7467.8% | 9.3% |
每股收益(稀释后)
AREC
CTVA
| Q4 25 | — | $-0.80 | ||
| Q3 25 | $-0.05 | $-0.47 | ||
| Q2 25 | — | $1.92 | ||
| Q1 25 | $-0.08 | $0.95 | ||
| Q4 24 | — | $-0.05 | ||
| Q3 24 | $-0.14 | $-0.76 | ||
| Q2 24 | — | $1.51 | ||
| Q1 24 | $-0.09 | $0.60 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $2.1M | $4.5B |
| 总债务越低越好 | — | $1.7B |
| 股东权益账面价值 | $-80.7M | $24.1B |
| 总资产 | $202.4M | $42.8B |
| 负债/权益比越低杠杆越低 | — | 0.07× |
8季度趋势,按日历期对齐
现金及短期投资
AREC
CTVA
| Q4 25 | — | $4.5B | ||
| Q3 25 | $2.1M | $2.6B | ||
| Q2 25 | — | $2.1B | ||
| Q1 25 | $24.6K | $2.0B | ||
| Q4 24 | $1.2M | $3.2B | ||
| Q3 24 | $991.7K | $2.5B | ||
| Q2 24 | $554.4K | $2.0B | ||
| Q1 24 | — | $1.7B |
总债务
AREC
CTVA
| Q4 25 | — | $1.7B | ||
| Q3 25 | — | $1.7B | ||
| Q2 25 | — | $1.7B | ||
| Q1 25 | — | $1.8B | ||
| Q4 24 | — | $2.0B | ||
| Q3 24 | — | $2.0B | ||
| Q2 24 | — | $2.5B | ||
| Q1 24 | — | $2.5B |
股东权益
AREC
CTVA
| Q4 25 | — | $24.1B | ||
| Q3 25 | $-80.7M | $25.2B | ||
| Q2 25 | — | $25.9B | ||
| Q1 25 | $-84.1M | $24.3B | ||
| Q4 24 | $-79.5M | $23.8B | ||
| Q3 24 | $-51.8M | $24.7B | ||
| Q2 24 | $-44.1M | $25.2B | ||
| Q1 24 | $-52.2M | $24.8B |
总资产
AREC
CTVA
| Q4 25 | — | $42.8B | ||
| Q3 25 | $202.4M | $42.2B | ||
| Q2 25 | — | $41.8B | ||
| Q1 25 | $203.6M | $42.1B | ||
| Q4 24 | $205.9M | $40.8B | ||
| Q3 24 | $211.6M | $41.9B | ||
| Q2 24 | $195.5M | $41.5B | ||
| Q1 24 | $216.1M | $43.6B |
负债/权益比
AREC
CTVA
| Q4 25 | — | 0.07× | ||
| Q3 25 | — | 0.07× | ||
| Q2 25 | — | 0.07× | ||
| Q1 25 | — | 0.07× | ||
| Q4 24 | — | 0.08× | ||
| Q3 24 | — | 0.08× | ||
| Q2 24 | — | 0.10× | ||
| Q1 24 | — | 0.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-8.0M | $4.4B |
| 自由现金流经营现金流 - 资本支出 | — | $4.2B |
| 自由现金流率自由现金流/营收 | — | 106.2% |
| 资本支出强度资本支出/营收 | — | 5.7% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $2.8B |
8季度趋势,按日历期对齐
经营现金流
AREC
CTVA
| Q4 25 | — | $4.4B | ||
| Q3 25 | $-8.0M | $193.0M | ||
| Q2 25 | — | $947.0M | ||
| Q1 25 | $-1.4M | $-2.1B | ||
| Q4 24 | $-3.7M | $4.2B | ||
| Q3 24 | $-4.3M | $130.0M | ||
| Q2 24 | $-8.5M | $451.0M | ||
| Q1 24 | $-4.8M | $-2.6B |
自由现金流
AREC
CTVA
| Q4 25 | — | $4.2B | ||
| Q3 25 | — | $36.0M | ||
| Q2 25 | — | $829.0M | ||
| Q1 25 | — | $-2.2B | ||
| Q4 24 | — | $4.0B | ||
| Q3 24 | $-4.8M | $-24.0M | ||
| Q2 24 | — | $337.0M | ||
| Q1 24 | — | $-2.8B |
自由现金流率
AREC
CTVA
| Q4 25 | — | 106.2% | ||
| Q3 25 | — | 1.4% | ||
| Q2 25 | — | 12.8% | ||
| Q1 25 | — | -49.9% | ||
| Q4 24 | — | 100.4% | ||
| Q3 24 | -2045.0% | -1.0% | ||
| Q2 24 | — | 5.5% | ||
| Q1 24 | — | -61.4% |
资本支出强度
AREC
CTVA
| Q4 25 | — | 5.7% | ||
| Q3 25 | — | 6.0% | ||
| Q2 25 | — | 1.8% | ||
| Q1 25 | — | 2.1% | ||
| Q4 24 | — | 4.6% | ||
| Q3 24 | 205.0% | 6.6% | ||
| Q2 24 | — | 1.9% | ||
| Q1 24 | — | 3.3% |
现金转化率
AREC
CTVA
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.72× | ||
| Q1 25 | — | -3.23× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.43× | ||
| Q1 24 | — | -6.23× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AREC
暂无分部数据
CTVA
| Corn | $1.4B | 35% |
| Herbicides | $1.1B | 27% |
| Insecticides | $488.0M | 12% |
| Fungicides | $272.0M | 7% |
| Biologicals | $191.0M | 5% |
| Soybean | $164.0M | 4% |
| Other | $160.0M | 4% |
| Otheroilseeds | $94.0M | 2% |